Martin Smatana studied at Oxford and Imerial College in London, where he graduated in health management. He worked in England as an analyst at a public health institute. From 2016 to 2020, he headed the Institute of Health Policy. He currently works in the field of artificial intelligence and works as an analyst for the World Bank, the International Monetary Fund and the European Commission. In addition, he cooperates with the Association for the Protection of Patients' Rights, is an advisor to the Ministry of Education, the Ministry of Labor, Social Affairs and the Family and the Chairman of the Supervisory Board of VšZP. He is the author of several publications and a member of the social protection committee of the European Commission.

He held the position of general director of the pharmacy and drug policy section at the Ministry of Health and was part of the team that in 2022 amended Act 363/2011 Coll. on the scope and conditions of reimbursement of medicines, medical devices and dietetic foods. In addition to the preparation of the amendment, he also participated in its implementation, when he was responsible for the creation and implementation of a strategy to catch up with the lagging behind in the availability of innovative medicines for Slovak patients. He worked in leading positions in the pharmaceutical industry for a long time. He currently works as a strategic consultant in the field of drug policy, pharmaco-economic evaluation of health technologies and ana…